Li, Jiao
Deng, Bo
Song, Wenli
Li, Keru
Ai, Jingwen
Liu, Xiaoni
Zhang, Haocheng
Zhang, Yi
Lin, Ke
Shao, Guofu
Liu, Chunfeng
Zhang, Wenhong
Chen, Xiangjun
Zhang, Yanlin
Funding for this research was provided by:
Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars (BK20200192)
Natural Science Research of Jiangsu Higher Education Institutions of China (20KJD320007)
Science and Technology Program of Suzhou (KJXW2019012)
Article History
Accepted: 14 November 2022
First Online: 25 November 2022
Declarations
:
: The clinical trial was approved by the ethics committee of The Second Affiliated Hospital of Soochow University (JD-LK-2021–079-02) and the ethical committee of Huashan Hospital Affiliated to Fudan University (KY 2021–451) and was registered in ClinicalTrial.gov of Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment (IMPROVE, NCT04946682).
: Written informed consent was obtained from the individual for the publication of any potentially identifiable images or data included in this article.
: The authors declare no competing interests.